Your session is about to expire
← Back to Search
Exergaming-Based Therapy for Stroke (ABCcare Trial)
ABCcare Trial Summary
This trial proposes to evaluate if exergaming-based therapy can help people with stroke regain motor function and reduce disability. It will also assess the safety, feasibility, compliance and efficacy of this therapy.
ABCcare Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowABCcare Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ABCcare Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research encompass subjects that are sixty or older?
"Within the confines of this medical trial, those aged between 45 and 90 can participate."
What characteristics make a person the ideal participant for this medical experiment?
"The candidate pool for this medical trial consists of 120 individuals aged 45 to 90 that have experienced a stroke in the past six months. In order to be eligible, these patients must also pass certain neurological impairment requirements as confirmed by their physician."
Are patients still eligible to participate in this clinical trial?
"According to information on clinicaltrials.gov, the recruiting for this trial has been discontinued since September 23rd 2023; however, there are 1128 other studies currently seeking patients. The trial was first posted on October 1st of 2023 and underwent its final update shortly before recruitment ended."
What is the goal of this medical experiment?
"This trial, which will be monitored at the Baseline (week 0), Mid-training (2nd week), Post-training laboratory (7th week) and Post-training home visit (10th week) seeks to improve voluntary balance control. Secondary objectives include quantifying real life falls through a fall log diary, measuring heart rate variability with Polar®heart rate monitor tests, and assessing arterial endothelial function via brachial artery flow-mediated vasodilation - FMD ultrasound imaging."
Share this study with friends
Copy Link
Messenger